Impact of NOL - Nociception Level Index Intraoperative Monitoring on Perioperative Outcomes in Spine Surgery - a Quality Improvement Pilot

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMedasense Biometrics Ltd

About this trial

The objective of this study is to evaluate the clinical impact of the NOL nociception level index monitoring on intraoperative and post operative patient outcomes and institutional metrics when used to guide intraoperative analgesia dosing in patients undergoing spine surgery under general anesthesia when compared to a case controlled retrospective cohort.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age > 18 years old.

ASA I-III

Elective spine surgery (laminectomy, spinal fusion, and disc replacement) under general anesthesia.

Opioid tolerant and patients with documented chronic pain may be included

Disqualifiers

• Use of any type of anesthesia other than general anesthesia (neuraxial, epidural analgesia or local regional anesthesia)

Use of intraoperative methadone

Non-sinus heart rate

Pregnancy/lactation

Trial design

Design model

Single group

Treatments tested in this trial

  • NOL guided intraoperative analgesia

    Device

    The PMD-200 monitor with the NOL index will be used to guide analgesia dosing during anesthesia maintenance as an adjunct monitor used alongside other anesthesia monitors. If the NOL value is above 25 for sixty seconds or more, clinicians will evaluate whether more analgesia is needed. If the NOL value is below 25 the patient is considered to have adequately managed nociception.

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: Retrospective cohortOther 1 intervention

Trial outcomes

Primary outcomes

1

Total opioid requirement during surgery and PACU stay

Total opioid requirement during surgery and PACU stay reported in morphine equivalents (mgs)

Time frame
One day

Secondary outcomes

1

Reduction in time to extubation

Reduction in time to extubation measured in minutes

Time frame
one day
2

Reduction in time to PACU discharge readiness

Reduction in time to PACU discharge readiness measured in minutes

Time frame
one day
3

Modified Aldrete Score

Modified Aldrete Score (scale of 0-10)

Time frame
one day
4

Reduction in PACU pain intensity rating

Reduction in PACU pain intensity rating (NRS scale of 0-10 )

Time frame
one day

Other outcomes

1

Ward recovery metrics - patient satisfaction levels

Patient reported satisfaction levels using standard QoR15 questionnaire responses in the NOL arm only

Time frame
three days
2

Intraoperative metrics - Hemodynamic instability

Reduction in hemodynamic instability (hypertensive are MAP above 120mmHg, hypotensive events are MAP below 65mmHg)

Time frame
One day
3

Intraoperative metrics - vasocative medication requirement

Use of vasoactive medication (ephedrine, phenylephrine, norepinephrine, atropine) total doses in mgs.

Time frame
One day
4

Ward recovery metrics - Pain Intensity

Pain intensity. Time points: NRS pain score on a scale of 0-10 , measurement frequency per hospital standard of care.

Time frame
three days

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Medasense Biometrics Ltd

Lead sponsor

Thomas Jefferson Health

Collaborator

This trial is not recruiting at the moment. You can still explore other options: